LLY 2026-08-22 Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk
JR Research NYSE
Novo Nordisk A S
NVO
2 articles
$204B Market cap · 2026-08-20
LLY 2026-08-22 JR Research 
Under The Hood, Novo Nordisk A/S ($NVO)
Novo Nordisk’s GLP-1 franchise transformed obesity treatment, while its valuation framework prices in 17 years of discounted cash flows.
Investor Letters
Letters that discuss NVO.
